Halozyme Therapeutics: New 52-Week Low Set Today (HALO)

Halozyme Therapeutics (NASDAQ:HALO) traded today at a new 52-week low of $7.97. This new low was reached on approximately average trading volume as 1.3 million shares traded hands,...